Uranium Energy Corp. (0LJQ)
London Stock Exchange · UK · prices in USD · close of 27 Oct 2026
Key indicators
| Last close | USD 8.020 |
|---|---|
| 52-week range | 7.145 – 20.339 |
| Return, 1 month / 3 months | −15.6% / −17.5% |
| Return, 1 year / 3 years | −40.1% / +45.6% |
| Trend | Below its 200-day average |
| RSI (14) | 41 |
| Volatility (1 year) | 77.4% |
| Worst drawdown (1 year) | -62.4% |
| Average daily value traded | 0.77M USD |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Uranium Energy Corp. is an American uranium mining company that explores for and produces uranium, the fuel used by nuclear power plants. It works mainly through in-situ recovery, a method that dissolves uranium underground and pumps it to the surface, and it operates projects in the United States, with activity centred in Texas and Wyoming. The company also owns processing and handling facilities that turn extracted uranium into a form utilities can use. Its customers are nuclear power generators and the wider nuclear fuel industry.
Uranium Energy Corp. trades under the code 0LJQ on the London Stock Exchange in UK, with its price quoted in US dollars (USD). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Uranium Energy Corp. (0LJQ) trades on the London Stock Exchange in UK. It last closed at USD 8.020 on 27 October 2026.
Its price-based Market X-Ray is 17 out of 100 (a weak price profile), ranking 3,531 of 3,788 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 40.1% and over the last three months it fell 17.5%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 7 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -36.7% | ||
| From 52-week high | -59.2% | ||
| Momentum | 11 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -17.5% | ||
| 6-month return | -47.4% | ||
| 12-month return, skipping the last month | -29.0% | ||
| Stability (higher is calmer) | 11 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 77.4% | ||
| Worst drawdown, 1 year (smaller is calmer) | -62.4% | ||
| Liquidity | 50 · Fair | Moderate trading activity. | |
| Average daily value traded | 0.77M USD | ||
| Zero-volume days | 0.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 0 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
- Stability (higher is calmer): Volatile, with deep drawdowns.
Returns
| 1 week | +1.3% |
|---|---|
| 1 month | −15.6% |
| 3 months | −17.5% |
| 6 months | −47.4% |
| 1 year | −40.1% |
| 3 years | +45.6% |
| 5 years | +108.3% |
Signals
| 50-day / 200-day average | 10.050 / 12.662 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.545 |
Technical summary
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.